Mexico 2025: The Life Sciences Agenda

Mexico 2025: The Life Sciences Agenda captures a sector in transformation. As public reforms expand IMSS Bienestar and private providers modernize care delivery, the report explores how policy, investment, and innovation are converging to build a more inclusive, digital, and resilient healthcare system. The analysis highlights the central role of the pharma and MedTech industries in expanding access and driving sustainable growth for Mexico’s health future.

Executive Forecast

November 12, 2025

Paulina Escobedo – Managing Director, LFB, Mexico

November 2025

Karla Baez –Directora Ejecutiva Interina, AMIIF, México

October 2025

From Competition to Collaboration: How Mexico's Healthcare Tech Leader is Breaking Down Industry Silos - Interview with Bruno Valera, Managing Director, Medikit, Mexico

September 2025

Rafael Dávila Poulat – General Manager, Eisai, Mexico

August 2025

Dr. Octavio González Chon – General Manager, Médica Sur, México

July 2025

Leading with Purpose in Mexico’s Healthcare Future: Interview with Horacio Garza - General Manager, Christus Muguerza, Mexico

July 2025

Jesús Martínez Castellanos – Director General, GNP Seguros, México

June 2025

Pushing toward Prevention and Early Diagnosis: Interview with João Carapeto - Country Manager, Roche Diagnostics, Mexico

June 2025

Driving real Impact across the full Spectrum of Care: Interview with Jorge Luis Caridad – Managing Director, Johnson & Johnson, Mexico

May 2025

Juan Esteban Moctezuma Barbará

No items found.